| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
38,920 |
37,914 |
$1.70M |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
21,360 |
18,811 |
$1.54M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
34,862 |
32,558 |
$1.28M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
16,947 |
16,638 |
$1.26M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
18,877 |
17,750 |
$1.08M |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
10,432 |
10,181 |
$782K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
4,112 |
4,012 |
$310K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
1,963 |
1,841 |
$202K |
| 99460 |
|
1,052 |
1,006 |
$72K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
3,933 |
3,877 |
$58K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
891 |
847 |
$45K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
892 |
844 |
$35K |
| 99215 |
Prolong outpt/office vis |
290 |
270 |
$23K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,316 |
1,239 |
$22K |
| 90834 |
Psychotherapy, 45 minutes with patient |
321 |
263 |
$20K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
3,286 |
3,100 |
$19K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,402 |
575 |
$14K |
| 96127 |
|
4,610 |
4,419 |
$12K |
| 0071A |
|
281 |
278 |
$10K |
| 99383 |
|
132 |
132 |
$10K |
| 0072A |
|
242 |
240 |
$9K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
262 |
252 |
$7K |
| 99462 |
|
305 |
285 |
$7K |
| 96161 |
|
293 |
281 |
$5K |
| 99173 |
|
916 |
892 |
$4K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
747 |
719 |
$4K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
37 |
36 |
$3K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
413 |
366 |
$2K |
| 90791 |
Psychiatric diagnostic evaluation |
22 |
22 |
$2K |
| 54150 |
|
12 |
12 |
$2K |
| 90480 |
|
104 |
104 |
$2K |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
24 |
24 |
$2K |
| 99381 |
|
24 |
24 |
$2K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
131 |
119 |
$1K |
| 99384 |
|
14 |
14 |
$980.00 |
| 99382 |
|
13 |
13 |
$910.00 |
| 99354 |
|
12 |
12 |
$788.00 |
| 0074A |
|
12 |
12 |
$480.00 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
24 |
24 |
$314.60 |
| 90670 |
|
9,216 |
9,026 |
$241.38 |
| 90651 |
|
1,174 |
1,153 |
$204.87 |
| 90686 |
|
8,762 |
8,588 |
$181.66 |
| 1003F |
|
24,589 |
23,973 |
$125.00 |
| 97802 |
|
24,588 |
23,971 |
$111.41 |
| 94664 |
|
12 |
12 |
$75.74 |
| 81002 |
|
29 |
24 |
$63.26 |
| 91307 |
|
701 |
662 |
$40.00 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
1,017 |
978 |
$4.71 |
| 90723 |
|
8,344 |
8,198 |
$0.01 |
| 99050 |
|
10,243 |
9,092 |
$0.00 |
| 90647 |
|
7,891 |
7,748 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
1,654 |
1,610 |
$0.00 |
| 90696 |
|
509 |
500 |
$0.00 |
| 3008F |
|
2,444 |
2,339 |
$0.00 |
| 1111F |
|
1,281 |
1,166 |
$0.00 |
| 90716 |
|
454 |
443 |
$0.00 |
| 90680 |
|
157 |
154 |
$0.00 |
| 90656 |
|
689 |
688 |
$0.00 |
| 90620 |
|
132 |
128 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
269 |
256 |
$0.00 |
| 3074F |
|
77 |
73 |
$0.00 |
| G9920 |
Screening performed and negative |
37,277 |
34,977 |
$0.00 |
| 90685 |
|
1,160 |
1,120 |
$0.00 |
| 90633 |
|
4,440 |
4,358 |
$0.00 |
| 90681 |
|
2,978 |
2,915 |
$0.00 |
| 98960 |
|
29,655 |
28,118 |
$0.00 |
| 90707 |
|
578 |
566 |
$0.00 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
106 |
102 |
$0.00 |
| 90671 |
|
2,723 |
2,690 |
$0.00 |
| 90734 |
|
988 |
965 |
$0.00 |
| 90715 |
|
342 |
339 |
$0.00 |
| 90710 |
|
527 |
515 |
$0.00 |
| G9919 |
Screening performed and positive and provision of recommendations |
66 |
65 |
$0.00 |
| 90700 |
|
281 |
273 |
$0.00 |
| 90461 |
|
459 |
422 |
$0.00 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
18 |
17 |
$0.00 |
| 91300 |
|
19 |
14 |
$0.00 |
| 91321 |
|
44 |
44 |
$0.00 |
| 3078F |
|
64 |
60 |
$0.00 |
| 90672 |
|
13 |
13 |
$0.00 |